NVO - Novo Nordisk A/S ADS

NVO valuation $122.54 billion

Stock Price

44.56
Change: ↓ -1.36 (-2.9617%)
Last Update: 2015-01-30T16:17:05-05:00
Shares Outstanding: 2,750,000,000
Industry: Biotechnology

Headquartered in Denmark, Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. Novo Nordisk employs approximately 40,700 employees in 75 countries, and markets its products in more than 180 countries.

Stock Price Data

Open: 45.20 Previous Close: 45.92
High: 45.33 Low: 44.53
Bid: 44.50 Ask: 47.00

Bid Size: 100 Ask Size: 700
Raw Bid Size: 1 Raw Ask Size: 7
Trade Volume: 8235 Share Volume: 1059385
Last Trade Date: 2015-01-30 Last Trade Time: 16:05:04-05:00
Vwap: 44.9000701 EPS: 1.72

Fundamental Data

PE ratio: 26.40 PB ratio: 21.423
Beta: 1.087802

52 Week High: 49.105 52 Week Low: 18.92
52 Week High Vwap: 48.9506 52 Week Low Vwap: 19.5911
52 Week High Volume: 9598532 52 Week Low Volume: 394354
52 Week Avg Volume: 1852406

Dividend Data

Dividend: 0.606122 Date: 2014-03-21
Amount: 0.303061 Yield: 0.66
Frequency: A Paydate: 2014-04-02
* Quotes delayed 15 minutes

Related Stocks

StockCompany namePrice
GILD Gilead Sciences Inc. 104.83
IMGN ImmunoGen Inc. 7.63
CELG Celgene Corporation 119.16
ARNA Arena Pharmaceuticals Inc. 4.31
MNKD MannKind Corporation 6.35
AMGN Amgen Inc 152.26
NVAX Novavax Inc. 7.81
BIIB Biogen Idec Inc. 389.16
NPSP NPS Pharmaceuticals Inc. 45.86
ARIA ARIAD Pharmaceuticals Inc. 6.45